Du L - Search Results

1

3D-printed cannabidiol hollow suppositories for treatment of epilepsy.

Wei M, Liu D, Xie H, Sun Y, Fang Y, Du L, Jin Y. Wei M, et al. Among authors: du l. Int J Pharm. 2024 Dec 26;670:125141. doi: 10.1016/j.ijpharm.2024.125141. Online ahead of print. Int J Pharm. 2024. PMID: 39732218 Review.

2

Mesalazine hollow suppositories based on 3D printing for treatment of ulcerative colitis.

Wei M, Liu D, Sun Y, Xie H, Du L, Jin Y. Wei M, et al. Among authors: du l. Int J Pharm. 2023 Jul 25;642:123196. doi: 10.1016/j.ijpharm.2023.123196. Epub 2023 Jul 1. Int J Pharm. 2023. PMID: 37399930

3

Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies.

Jin Y, Lian Y, Du L, Wang S, Su C, Gao C. Jin Y, et al. Among authors: du l. Int J Pharm. 2012 Jul 1;430(1-2):276-81. doi: 10.1016/j.ijpharm.2012.03.046. Epub 2012 Apr 1. Int J Pharm. 2012. PMID: 22486963

4

Riboflavin laurate nanosuspensions as an intramuscular injection for long-term riboflavin supplementation.

Du L, Li G, Jin Y, Wang L, Xu Q, Dong J. Du L, et al. Int J Pharm. 2013 Jun 25;450(1-2):338-44. doi: 10.1016/j.ijpharm.2013.04.005. Epub 2013 Apr 12. Int J Pharm. 2013. PMID: 23583503

5

Transdermal enhancement effect and mechanism of iontophoresis for non-steroidal anti-inflammatory drugs.

Zuo J, Du L, Li M, Liu B, Zhu W, Jin Y. Zuo J, et al. Among authors: du l. Int J Pharm. 2014 May 15;466(1-2):76-82. doi: 10.1016/j.ijpharm.2014.03.013. Epub 2014 Mar 5. Int J Pharm. 2014. PMID: 24607207

6

Transdermal delivery of the in situ hydrogels of curcumin and its inclusion complexes of hydroxypropyl-β-cyclodextrin for melanoma treatment.

Sun Y, Du L, Liu Y, Li X, Li M, Jin Y, Qian X. Sun Y, et al. Among authors: du l. Int J Pharm. 2014 Jul 20;469(1):31-9. doi: 10.1016/j.ijpharm.2014.04.039. Epub 2014 Apr 18. Int J Pharm. 2014. PMID: 24746691

7

Self-assembled drug delivery systems. Part 7: hepatocyte-targeted nanoassemblies of an adefovir lipid derivative with cytochrome P450-triggered drug release.

Du L, Wu L, Jin Y, Jia J, Li M, Wang Y. Du L, et al. Int J Pharm. 2014 Sep 10;472(1-2):1-9. doi: 10.1016/j.ijpharm.2014.06.020. Epub 2014 Jun 11. Int J Pharm. 2014. PMID: 24929012

8

Nasal timosaponin BII dually sensitive in situ hydrogels for the prevention of Alzheimer's disease induced by lipopolysaccharides.

Chen W, Li R, Zhu S, Ma J, Pang L, Ma B, Du L, Jin Y. Chen W, et al. Among authors: du l. Int J Pharm. 2020 Mar 30;578:119115. doi: 10.1016/j.ijpharm.2020.119115. Epub 2020 Feb 8. Int J Pharm. 2020. PMID: 32045690

9

Paclitaxel-in-liposome-in-bacteria for inhalation treatment of primary lung cancer.

Zhang M, Li M, Du L, Zeng J, Yao T, Jin Y. Zhang M, et al. Among authors: du l. Int J Pharm. 2020 Mar 30;578:119177. doi: 10.1016/j.ijpharm.2020.119177. Epub 2020 Feb 24. Int J Pharm. 2020. PMID: 32105724

10

Intranasal tetrandrine temperature-sensitive in situ hydrogels for the treatment of microwave-induced brain injury.

Zhang L, Pang L, Zhu S, Ma J, Li R, Liu Y, Zhu L, Zhuang X, Zhi W, Yu X, Du L, Zuo H, Jin Y. Zhang L, et al. Among authors: du l. Int J Pharm. 2020 Jun 15;583:119384. doi: 10.1016/j.ijpharm.2020.119384. Epub 2020 May 1. Int J Pharm. 2020. PMID: 32371003

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,204 results

Search Page

Filters